MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor

Fajun Qu, Xingang Cui, Hong Yi, +7

Molecular and Cellular Biochemistry

Androgen ReceptorUrologyMedicineCancer BiologyMicrorna-185 Suppresses Proliferation +7

MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma

Fajun Qu, Jianqing Ye, Xiuwu Pan, +8

Journal of drug targeting

Tumor BiologyUrologyCancer ImmunosurveillancePd-l1 ExpressionPd-l1 Inhibitors +13

IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway

Xi Liu, Lu Chen, Yinghui Fan, +10

Cell Death and Disease

EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling

Xiuwu Pan, Lu Chen, Hong Yi, +12

International Journal of Oncology

Genitourinary CancerCyclin B1/cdk1G2/m ArrestEif3d Mrna ExpressionMedicine +10

Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysis

Xiuwu Pan, Hao Zhang, Da Xu, +11

International Journal of Biological Sciences

Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells

Sishun Gan, Jian-Qing Ye, Lei Wang, +5

OncoTargets and Therapy

SMC1A promotes growth and migration of prostate cancer in vitro and in vivo

Xiuwu Pan, Sishun Gan, Jian-Qing Ye, +14

International Journal of Oncology

UrologyStructural MaintenanceMedicinePathologyCancer Genomics +11

Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma

Qiwei Yang, Ye Wang, Xiuwu Pan, +7

Oncotarget

TROAP regulates prostate cancer progression via the WNT3/survivin signalling pathways

Jianqing Ye, Chuanmin Chu, Ming Chen, +9

Oncology Reports

High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer

Xi Liu, Lu Chen, Hai Huang, +9

Oncotarget